Biolase Return on Tangible Equity 2010-2023 | BIOL

Current and historical return on tangible equity values for Biolase (BIOL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Biolase Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.04B $-0.00B -1381.82%
2023-09-30 $-0.03B $0.00B -742.86%
2023-06-30 $-0.03B $0.00B -527.27%
2023-03-31 $-0.03B $0.01B -324.32%
2022-12-31 $-0.03B $0.00B -232.00%
2022-09-30 $-0.02B $0.01B -137.14%
2022-06-30 $-0.02B $0.02B -88.37%
2022-03-31 $-0.01B $0.02B -57.73%
2021-12-31 $-0.02B $0.02B -58.18%
2021-09-30 $-0.02B $0.03B -71.58%
2021-06-30 $-0.03B $0.03B -156.96%
2021-03-31 $-0.04B $0.03B -297.87%
2020-12-31 $-0.03B $0.01B -1133.33%
2020-09-30 $-0.03B $0.01B -2133.33%
2020-06-30 $-0.02B $-0.00B 888.89%
2020-03-31 $-0.02B $-0.00B 1266.67%
2019-12-31 $-0.02B $0.00B -3600.00%
2019-09-30 $-0.02B $-0.00B -933.33%
2019-06-30 $-0.02B $0.00B -323.08%
2019-03-31 $-0.02B $0.00B -209.52%
2018-12-31 $-0.02B $0.01B -146.67%
2018-09-30 $-0.02B $0.01B -117.95%
2018-06-30 $-0.02B $0.02B -110.84%
2018-03-31 $-0.02B $0.02B -100.00%
2017-12-31 $-0.02B $0.03B -103.70%
2017-09-30 $-0.02B $0.02B -108.11%
2017-06-30 $-0.02B $0.02B -91.14%
2017-03-31 $-0.02B $0.02B -98.63%
2016-12-31 $-0.02B $0.02B -93.51%
2016-09-30 $-0.01B $0.02B -65.00%
2016-06-30 $-0.02B $0.02B -75.00%
2016-03-31 $-0.02B $0.02B -78.26%
2015-12-31 $-0.02B $0.02B -71.03%
2015-09-30 $-0.02B $0.02B -67.74%
2015-06-30 $-0.02B $0.03B -69.72%
2015-03-31 $-0.02B $0.03B -88.89%
2014-12-31 $-0.02B $0.04B -135.85%
2014-09-30 $-0.02B $0.01B -336.84%
2014-06-30 $-0.02B $0.00B -400.00%
2014-03-31 $-0.01B $0.01B -254.55%
2013-12-31 $-0.01B $0.01B -218.18%
2013-09-30 $-0.01B $0.01B -138.46%
2013-06-30 $-0.01B $0.01B -88.89%
2013-03-31 $-0.01B $0.01B -66.67%
2012-12-31 $-0.00B $0.01B -48.48%
2012-09-30 $-0.01B $0.01B -84.85%
2012-06-30 $-0.01B $0.01B -75.68%
2012-03-31 $-0.01B $0.01B -58.54%
2011-12-31 $-0.01B $0.01B -60.61%
2011-09-30 $-0.00B $0.01B -66.67%
2011-06-30 $-0.01B $0.01B inf%
2011-03-31 $-0.01B $0.00B 188.24%
2010-12-31 $-0.01B $-0.01B 252.63%
2010-09-30 $-0.01B $-0.01B 650.00%
2010-06-30 $-0.01B $-0.01B -720.00%
2010-03-31 $-0.00B $-0.00B -85.71%
2009-12-31 $-0.00B $0.01B -75.00%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.005B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33